Page 166 - 南京医科大学自然版
P. 166
第46卷第9期
·1436 · 南 京 医 科 大 学 学 报 2026年9月
case report[J]. Int J Infect Dis,2021,107:176-178 (4):316-318
[17]杨 燕,曾 谊. 非结核分枝杆菌肺病170例回顾性分 [24]SLANY M,JEZEK P,BODNAROVA M. Fish tank
析[J]. 南京医科大学学报(自然科学版),2021,41(7): granuloma caused by Mycobacterium marinum in two aqu⁃
1058-1062 arists:two case reports[J]. Biomed Res Int,2013,2013:
YANG Y,ZENG Y. A Retrospective analysis of 170 cases 161329
of nontuberculous mycobacterial lung disease[J]. Journal [25]FLONDELL M,ORNSTEIN K,BJÖRKMAN A. Invasive
of Nanjing Medical University(Natural Sciences),2021, Mycobacterium marinum infection of the hand[J]. J Plast
41(7):1058-1062 Surg Hand Surg,2013,47(6):532-534
[18]STRASZEWSKI A,TROYER S,BOYER M I,et al. Utility [26]PAPATHEMELI D,FRANKE I,BONNEKOH B,et al.
of routine histopathologic and culture analysis in wrist Explosive generalization of nodular vasculitis⁃Mycobacte⁃
tenosynovectomy[J]. J Hand Surg Am,2026,51(5):576 rium marinum challenges the paradigm[J]. J Eur Acad
[19]SUHLING M,DUTT A,COOK O,et al. Disseminated Dermatol Venereol,2016,30(12):189-191
Mycobacterium marinum presenting as bursitis in a [27]LATA C J,EDGAR K,VAUGHAN S. Clinical implications
patient with psoriatic arthritis on adalimumab[J]. JAAD for the timely diagnosis of Mycobacterium marinum in the
Case Rep,2026,67:55-58 age of biologic therapy:a case report and review of the
[20]FEISCHEN M,JORDAN S,KALSDORF B,et al. A case literature[J]. Case Rep Infect Dis,2017,2017:5274302
of complicated Mycobacterium marinum infection ⁃“nihil [28]SHAHRIARI N ,LACHANCE A,SLOAN B,et al.
nocere”in differential diagnostic and therapy[J]. Dtsch Mycobacterium marinum infection masquerading as infla⁃
Med Wochenschr,2025,150(17):1046-1049 mmatory arthropathy[J]. J Am Acad Dermatol,2019,81
[21]THANOU⁃STAVRAKI A,SAWALHA A H,CROWSON (4):AB243
A N,et al. Noodling and Mycobacterium marinum infection [29]SCHUBERT N,SCHILL T,PLÜß M,et al. Flare or foe?⁃
mimicking seronegative rheumatoid arthritis complicated Mycobacterium marinum infection mimicking rheumatoid
by anti⁃tumor necrosis factor α therapy[J]. Arthritis Care arthritis tenosynovitis:case report and literature review[J].
Res,2011,63(1):160-164 BMC Rheumatol,2020,4:11
[22]MACEK P,BODNAROVA M,ZAVADA J,et al. Mycobac⁃ [30]JOYO Y,YASUMA S,USAMI T,et al. Nontuberculous
terium marinum epididymoorchitis:case report and litera⁃ mycobacteriosis oligoarthritis of the right hand misdiagn ⁃
ture review[J]. Urol Int,2011,87(1):120-124 osed as rheumatoid arthritis:a case report[J]. Mod Rheu⁃
[23]FURER V,FRANKS A G,MAGRO C M,et al. Musculo⁃ matol Case Rep,2023,8(1):16-20
skeletal ultrasound prompts a rare diagnosis of Mycobacte⁃ (收稿:2026-02-13;修回:2026-05-20;录用:2026-05-30)
rium marinum infection[J]. Scand J Rheumatol,2012,41 (本文编辑:陈汐敏)
(上接第1420页) bladder cancer[J]. Cancer Res,2025,85(12):2288-2301
[74]CIFCI D,FOERSCH S,KATHER J N. Artificial intelli⁃ [78]ZHAO H Y,GAO X C,JIANG Y K,et al. Targeting CO⁃
gence to identify genetic alterations in conventional PA to enhance erdafitinib sensitivity in FGFR ⁃ altered
histopathology[J]. J Pathol,2022,257(4):430-444 bladder cancer[J]. Adv Sci(Weinh),2025,12(18):
[75]HOSNI S,KILIAN V,KLÜMPER N,et al. Adipocyte pre⁃ e2413209
cursor⁃derived NRG1 promotes resistance to FGFR inhibi⁃ [79]YANG Y Y,HE X J,LI Z L,et al. Design,synthesis and
tion in urothelial carcinoma[J]. Cancer Res,2024,84 biological evaluation of indazole derivatives as selective
(5):725-740 covalent inhibitors of FGFR4 in wild⁃type and gatekeeper
[76]CAVAZZONI A,SALAMON I,FUMAROLA C,et al. Syn⁃ mutants[J]. Eur J Med Chem,2023,258:115628
ergic activity of FGFR2 and MEK inhibitors in the treat⁃ [80]NG C F,GLASPY J,PLACENCIO⁃HICKOK V R,et al. Ex⁃
ment of FGFR2 ⁃ amplified cancers of unknown primary ceptional response to erdafitinib in FGFR2⁃mutated meta⁃
[J]. Mol Ther,2024,32(10):3650-3668 static pancreatic ductal adenocarcinoma[J]. J Natl Com⁃
[77]YU Y C,GAO X C,ZHAO H Y,et al. A genome⁃wide syn⁃ pr Canc Netw,2022,20(10):1076-1079
thetic lethal screen identifies spermidine synthase as a (收稿:2026-05-28;修回:2026-07-04;录用:2026-07-06)
target to enhance erdafitinib efficacy in FGFR ⁃ mutant (本文编辑:唐 震)

